| 21-May-13 05:40PM | Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03:30 PM at Seeking Alpha |
| 15-May-13 07:34AM | The Young And Restless Retirement Portfolio: Stay The Course at Seeking Alpha |
| 06:01AM | InPlay: Achillion Pharma appoints David Apelian as Chief Medical Officer and expands clinical operations team Briefing.com |
| 06:00AM | Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team GlobeNewswire |
| 14-May-13 01:04PM | ACHILLION PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 10-May-13 01:22PM | Achillion: Down But Not Out And Progress Being Made at Seeking Alpha |
| 09-May-13 06:00AM | Achillion to Present at Three Upcoming Investor Conferences GlobeNewswire |
| 07-May-13 09:10AM | ACHILLION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06:00AM | Achillion Reports First Quarter 2013 Financial Results GlobeNewswire |
| 02-May-13 04:22PM | Gilead Misses Analysts Estimates on Sales of HIV Drugs at Bloomberg |
| 12:04PM | Oversold Conditions For Achillion Pharmaceuticals at TheStreet |
| 30-Apr-13 01:21PM | Young And Restless Portfolio: BlackBerry Will Be The Catalyst at Seeking Alpha |
| 28-Apr-13 11:45AM | This Week in Biotech at Motley Fool |
| 26-Apr-13 12:41PM | Large Market Opportunity in HCV Space Due to Unmet Medical Need, Large Reservoir of Patients and Current Standard of Care Wall Street Transcript +5.87% |
| 23-Apr-13 08:02PM | Tough Day for This Hepatitis C Underdog at Motley Fool |
| 06:08AM | Achillion presents data on ACH-3102 to treat Hepatitis C at theflyonthewall.com |
| 06:03AM | InPlay: Achillion Pharma announces updated Phase 2 results including early sustained virologic response on ACH-3102 plus ribavirin in genotype 1b treatment-naive hepatitis C patients; ACH-3102 deemed safe and well-tolerated Briefing.com |
| 06:03AM | Achillion Presents New Data on ACH-3102 to Treat Hepatitis C at the International Liver Congress GlobeNewswire |
| 06:00AM | Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients at Bloomberg |
| 06:00AM | Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients GlobeNewswire |
| 17-Apr-13 04:16PM | Achillion's HCV Candidates Progress Zacks |
| 16-Apr-13 05:49PM | 1 Biotech Challenging the Hep-C Goliath at Motley Fool |
| 11:05AM | Achillion: Moving Beyond Sofosbuvir's Shadow at Seeking Alpha |
| 06:32AM | Achillion initiates Phase 2 Interferon-free trial of sovaprevir and ACH-3102 theflyonthewall.com |
| 06:30AM | Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV GlobeNewswire |
| 05-Apr-13 05:52PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 04-Apr-13 10:55AM | Achillion shares defended at Deutsche Bank theflyonthewall.com |
| 03-Apr-13 10:40AM | Three Biotech Giants to Look For at Motley Fool -5.23% |
| 28-Mar-13 04:06PM | Gilead Hits Record High on Analysts View of Higher Sales at Bloomberg |
| 03:04PM | 3 Biotech Stars Ready To Shine at Seeking Alpha |
| 12:52PM | Gilead Hits Record High on Analysts View of Higher Sales at Bloomberg |
| 27-Mar-13 08:17PM | The Young And Restless Portfolio: Waiting For BlackBerry To Explode! at Seeking Alpha |
| 15-Mar-13 11:20AM | The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert at Seeking Alpha |
| 13-Mar-13 09:51PM | Achillion: A Tiny Biopharmaceutical Stock With Tremendous Potential at Seeking Alpha |
| 02:20PM | Achillion Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 08:00 AM at Seeking Alpha |
| 07-Mar-13 08:20AM | New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012 Marketwired |
| 08:20AM | New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012 Marketwire |
| 06-Mar-13 11:43AM | Retirement Portfolio Management: Selling Netflix Into Strength And Buying Achillion For Strength at Seeking Alpha +5.20% |
| 05:45AM | Bulls take a dose of Achillion Pharma optionMONSTER |
| 04-Mar-13 11:15AM | Gilead Sciences Will Likely Beat Revenue Consensus and 3 Analyst Notes Making Waves at Wall St. Cheat Sheet +6.75% |
| 01-Mar-13 06:45AM | Achillion to Present at Two Upcoming Investor Conferences GlobeNewswire |
| 28-Feb-13 05:29PM | The Young And Restless Update: This Aggressive Portfolio Is A Premium Performer at Seeking Alpha |
| 27-Feb-13 04:30PM | Achillion Pharmaceuticals Announces Closing of Public Offering GlobeNewswire |
| 01:01PM | Hepatitis C In Play for 2013? at Motley Fool |
| 26-Feb-13 01:06PM | ACHILLION PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 25-Feb-13 04:41PM | Secondary Offerings: What You Need to Know at Motley Fool -5.53% |
| 04:36PM | Snag ACHN Even Lower Than Its Secondary? at Forbes |
| 24-Feb-13 06:16PM | Retirement Portfolio Management Takes Focus, Discipline And Implementation at Seeking Alpha |
| 22-Feb-13 04:30PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 04:09PM | ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 21-Feb-13 08:00PM | Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire -10.81% |
| 06:43PM | Share Offerings By Hot Stocks Add To Earnings Season Risks Investor's Business Daily |
| 06:36PM | New Star Analyst Rankings for Achillion Pharmaceuticals, Inc. StarMine |
| 05:19PM | Why Achillion Pharmaceuticals Shares Dove at Motley Fool |
| 04:58PM | Aches And Pains Shouldn't Obscure Achillion's Potential at Seeking Alpha |
| 10:45AM | Achillion Pharma Offers Attractive Entry Point and 4 Stock Analyses Attracting Attention at Wall St. Cheat Sheet |
| 20-Feb-13 10:10PM | Achillion Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 04:14PM | ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online |
| 04:08PM | InPlay: Achillion Pharma announces underwritten public offering of $125 mln of its common stock Briefing.com |
| 04:08PM | Achillion Reports 2012 Fourth Quarter and Year-End Financial Results GlobeNewswire |
| 04:07PM | Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire |
| 04:01PM | ACHILLION PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 07:07AM | Q4 2012 Achillion Pharmaceuticals Inc. Earnings Release - After Market Close CCBN |
| 19-Feb-13 04:24PM | Gilead Stock Hits New High As HCV Drug Keeps Rocking at Investor's Business Daily |
| 04:05PM | Achillion to Report Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on February 20, 2013 GlobeNewswire |
| 14-Feb-13 02:11PM | Five stocks making moves at MarketWatch |
| 02:11PM | Five stocks making moves at MarketWatch |
| 13-Feb-13 11:22AM | Large Pharma May Get Involved As Achillion Hep C Pipeline Advances at Seeking Alpha +6.68% |
| 07:01AM | ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online |
| 11-Feb-13 07:05PM | Time To Buy Zynga For The Young And Restless Portfolio at Seeking Alpha |
| 10-Feb-13 09:38PM | Disappointing Fourth Quarter - Reason to Sell? at Motley Fool |
| 08-Feb-13 06:55AM | Achillion to Present at the 2013 Leerink Swann Global Healthcare Conference GlobeNewswire |
| 04-Feb-13 08:20AM | U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous Marketwire |
| 31-Jan-13 11:30AM | U.S. Stock Options With Biggest Changes in Implied Volatility at Bloomberg |
| 17-Jan-13 06:55AM | Achillion to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference GlobeNewswire |
| 16-Jan-13 11:44AM | JPMorgan Healthcare Conference Highlights: Idenix Pharmaceuticals at Motley Fool |
| 11:06AM | Life Sciences: Upcoming Events for Week of January 13 at Motley Fool |
| 14-Jan-13 04:19PM | Achillion Continues To Make Significant Strides In The Fight Against Hepatitis C at Seeking Alpha |
| 11-Jan-13 02:22PM | The Most Important New Drug of 2012 at Motley Fool |
| 09-Jan-13 08:23AM | Why Achillion Pharmaceuticals' Shares Soured at Motley Fool |
| 08:20AM | Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013 Marketwire |
| 08-Jan-13 02:08PM | 4 Biotech Stocks Spiking on Unusual Volume at TheStreet +5.60% |
| 01:33PM | Nasdaq stocks posting largest percentage decreases AP |
| 07-Jan-13 06:03PM | Nasdaq stocks posting largest percentage decreases AP -9.31% |
| 02:39PM | Nasdaq stocks posting largest percentage decreases AP |
| 12:17PM | This Hepatitis-C Player Is Struggling Today at Motley Fool |
| 10:29AM | The Young And Restless Portfolio: Adding A Tiny Biopharma Stock at Seeking Alpha |
| 07:06AM | Achillion reports interim results on ACH-3102 theflyonthewall.com |
| 06:56AM | InPlay: Achillion Pharma reports interim results on ACH-3102; enrollment completed in pilot Phase 2a study of ACH-3102 and ribavirin for genotype 1b CC patients Briefing.com |
| 02-Jan-13 02:29PM | AbbVie: Pharma's New Kid on the Block at Motley Fool +7.87% |
| 11:30AM | U.S. Stock Options With Biggest Changes in Implied Volatility at Bloomberg |
| 06:11AM | Achillion: Poised For Growth And Now Is The Time To Buy at Seeking Alpha |
| 27-Dec-12 09:00PM | 2012 Roundup -- HCV Treatments at Motley Fool |
| 26-Dec-12 04:16AM | Downside position in Achillion Pharma optionMONSTER |
| 21-Dec-12 04:17PM | ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 14-Dec-12 03:16PM | Will Kalydeco Push Vertex Higher? at Motley Fool |
| 03:12PM | As Competitors Pursue Alternatives One Biotech Gains Prominence for its Potential to Treat Hepatitis Thomson Reuters ONE |
| 03:12PM | As Competitors Pursue Alternatives One Biotech Gaining Prominence for Potential to Treat Hepatitis Thomson Reuters ONE |
| 03:12PM | As Competitors Pursue Alternatives Medgenics' INFRADURE Gains Prominence for its Potential to Treat Hepatitis Thomson Reuters ONE |
| 13-Dec-12 09:54AM | Monsanto Gains Market Share and 4 Stock Analyses to Follow at Wall St. Cheat Sheet |
